| __timestamp | Soleno Therapeutics, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 2242216 | 855506000 |
| Thursday, January 1, 2015 | 4536244 | 996170000 |
| Friday, January 1, 2016 | 5184803 | 1047690000 |
| Sunday, January 1, 2017 | 3068742 | 1324625000 |
| Monday, January 1, 2018 | 7178000 | 1416476000 |
| Tuesday, January 1, 2019 | 16267000 | 1754540000 |
| Wednesday, January 1, 2020 | 23191000 | 1829537000 |
| Friday, January 1, 2021 | 21453000 | 3051100000 |
| Saturday, January 1, 2022 | 15265000 | 2540300000 |
| Sunday, January 1, 2023 | 25189000 | 3162900000 |
| Monday, January 1, 2024 | 3630300000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Vertex Pharmaceuticals Incorporated and Soleno Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Vertex Pharmaceuticals has consistently outpaced Soleno Therapeutics in R&D spending, with an average annual investment nearly 150 times greater. In 2023, Vertex's R&D expenses peaked at approximately $3.16 billion, marking a 270% increase from 2014. Meanwhile, Soleno's R&D spending, though more modest, showed a significant upward trend, culminating in a 2023 investment of around $25 million, over 11 times its 2014 expenditure.
This disparity highlights the scale and ambition of Vertex's research initiatives, while Soleno's steady growth reflects its strategic focus on targeted innovation. As these companies continue to evolve, their R&D strategies will undoubtedly shape their future trajectories.
Eli Lilly and Company or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
AstraZeneca PLC or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.
R&D Insights: How Vertex Pharmaceuticals Incorporated and Viatris Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Exelixis, Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Vertex Pharmaceuticals Incorporated vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Vertex Pharmaceuticals Incorporated and Novavax, Inc.
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Soleno Therapeutics, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Soleno Therapeutics, Inc.